Lok AS - Search Results

1

Reply to: "Expert opinion vs. meta-analysis: To be or not to be?".

Papatheodoridis GV, Lekakis V, Lok AS, Reddy KR. Papatheodoridis GV, et al. Among authors: lok as. J Hepatol. 2023 Mar;78(3):e105-e106. doi: 10.1016/j.jhep.2022.11.027. Epub 2022 Dec 13. J Hepatol. 2023. PMID: 36521569 No abstract available.

2

Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.

Terrault NA, Stravitz RT, Lok AS, Everson GT, Brown RS Jr, Kulik LM, Olthoff KM, Saab S, Adeyi O, Argo CK, Everhart JE, Rodrigo del R; A2ALL Study Group. Terrault NA, et al. Among authors: lok as. Hepatology. 2014 Apr;59(4):1311-9. doi: 10.1002/hep.26920. Epub 2014 Mar 1. Hepatology. 2014. PMID: 24677192 Free PMC article.

3

Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort.

Sanyal AJ, Munoz B, Cusi K, Barritt AS 4th, Muthiah M, Mospan AR, Reddy KR, Firpi-Morell R, Thuluvath PJ, Bhamidimarri KR, Fried MW; TARGET-NASH Investigators. Sanyal AJ, et al. Clin Gastroenterol Hepatol. 2023 Oct;21(11):2889-2900.e10. doi: 10.1016/j.cgh.2023.02.024. Epub 2023 Mar 5. Clin Gastroenterol Hepatol. 2023. PMID: 36871772

4

Reply: Enhancing automated speech analysis for hepatic encephalopathy detection.

Bloom PP, Lok AS. Bloom PP, et al. Among authors: lok as. Hepatology. 2024 Nov 7. doi: 10.1097/HEP.0000000000001151. Online ahead of print. Hepatology. 2024. PMID: 39509361 No abstract available.

5

Medically Tailored Meals for Patients With Cirrhosis and Hepatic Encephalopathy: The BRAINFOOD Proof-of-concept Trial.

Tapper EB, Saleh ZM, Nikirk S, Bajaj J, Chen X, Lok AS. Tapper EB, et al. Among authors: lok as. J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101439. doi: 10.1016/j.jceh.2024.101439. Epub 2024 May 7. J Clin Exp Hepatol. 2024. PMID: 38882178

6

HEAR-MHE study: Automated speech analysis identifies minimal hepatic encephalopathy and may predict future overt hepatic encephalopathy.

Bloom PP, Fisher CJ, Tedesco N, Kamdar N, Garrido-Trevino L, Robin J, Asrani SK, Lok AS. Bloom PP, et al. Among authors: lok as. Hepatology. 2024 Sep 12. doi: 10.1097/HEP.0000000000001086. Online ahead of print. Hepatology. 2024. PMID: 39264936

7

[No title available]

[No authors listed] [No authors listed] PMID: 38639676

8

Implementation of a randomized mobile-technology lifestyle program in individuals with nonalcoholic fatty liver disease.

Tincopa MA, Patel N, Shahab A, Asefa H, Lok AS. Tincopa MA, et al. Among authors: lok as. Sci Rep. 2024 Mar 28;14(1):7452. doi: 10.1038/s41598-024-57722-7. Sci Rep. 2024. PMID: 38548875 Free PMC article. Clinical Trial.

9

What is in a name? Toward culturally sensitive nomenclature for liver disease in the east and west.

Kim 金雄來 WR, Iwakiri 岩切泰子 Y, Lok 駱淑芳 ASF. Kim 金雄來 WR, et al. Hepatology. 2023 Oct 1;78(4):1032-1034. doi: 10.1097/HEP.0000000000000410. Epub 2023 Apr 19. Hepatology. 2023. PMID: 37070237 No abstract available.

10

Response to "Reflections on the Study of Physiological Determinants in Cirrhosis With Ascites".

Mazumder NR, Tapper EB, Lok AS. Mazumder NR, et al. Among authors: lok as. United European Gastroenterol J. 2024 Dec 26. doi: 10.1002/ueg2.12748. Online ahead of print. United European Gastroenterol J. 2024. PMID: 39724451 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

634 results

Search Page

Filters